ProCE Banner Activity

Optimizing Antimicrobial Management and Tackling Resistance in Gram-Negative HAP/VAP Infections


In this downloadable slideset, learn about the role of novel agents in the management of HAP/VAP, approaches to identify patients at risk for multidrug–resistant organisms based on local resistance patterns and patient-specific factors, along with strategies, such as rapid diagnostic testing, advanced antibiograms, and clinical prediction scores, to help reduce time to effective therapy.

Released: May 09, 2023



Kayla R. Stover Hielscher

Kayla R. Stover Hielscher, PharmD, BCIDP, BCPS, FCCP, FIDSA

Professor of Pharmacy Practice
Program Director, PGY2 Infectious Diseases Residency
University of Mississippi Medical Center
Jackson, Mississippi

Trevor Van Schooneveld

Trevor Van Schooneveld, MD, FSHEA, FACP

Professor, Division of Infectious Diseases
Program Director, Infectious Diseases Fellowship
Medical Director, Antimicrobial Stewardship Program
University of Nebraska Medical Center
Omaha, Nebraska 

Provided by

Provided by ProCE, LLC and Clinical Care Options, LLC, in partnership with the Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner
ProCE Banner


Supported by educational grants from Merck Sharp & Dohme, LLC.

Merck Sharp & Dohme, LLC


Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner